Insider Trading Alert - NDAQ, UNTD, MS, SLH And OPK Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Friday, Nov. 15, 2013, 163 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $60.69 to $52,812,500,000.00.

Highlighted Stocks Traded by Insiders:

NASDAQ OMX Group (NDAQ) - FREE Research Report

Knight Edward S who is Executive Vice President at NASDAQ OMX Group sold 11,391 shares at $36.77 on Nov. 15, 2013. Following this transaction, the Executive Vice President owned 130,503 shares meaning that the stake was reduced by 8.03% with the 11,391 share transaction.

The shares most recently traded at $37.46, up $0.69, or 1.84% since the insider transaction. Historical insider transactions for NASDAQ OMX Group go as follows:

  • 4-Week # shares sold: 58,720
  • 12-Week # shares sold: 58,720
  • 24-Week # shares sold: 162,767

The average volume for NASDAQ OMX Group has been 1.3 million shares per day over the past 30 days. NASDAQ OMX Group has a market cap of $6.2 billion and is part of the financial sector and financial services industry. Shares are up 48.86% year to date as of the close of trading on Friday.

The NASDAQ OMX Group, Inc. delivers trading, clearing, exchange technology, regulatory, securities listing, and public company services worldwide. The stock currently has a dividend yield of 1.44%. The company has a P/E ratio of 19.2. Currently there are 8 analysts that rate NASDAQ OMX Group a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on NDAQ - FREE

TheStreet Quant Ratings rates NASDAQ OMX Group as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations, increase in net income, solid stock price performance and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full NASDAQ OMX Group Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

United Online (UNTD) - FREE Research Report

Scott Carol who is Director at United Online sold 5,257 shares at $18.79 on Nov. 15, 2013. Following this transaction, the Director owned 864 shares meaning that the stake was reduced by 85.88% with the 5,257 share transaction.

The shares most recently traded at $18.25, down $0.54, or 2.97% since the insider transaction. Historical insider transactions for United Online go as follows:

  • 12-Week # shares sold: 300
  • 24-Week # shares sold: 2.0 million

The average volume for United Online has been 1.1 million shares per day over the past 30 days. United Online has a market cap of $250.0 million and is part of the services sector and specialty retail industry. Shares are down 66.8% year to date as of the close of trading on Friday.

United Online, Inc., through its subsidiaries, provides consumer products and services over the Internet primarily in the United States, Canada, and Europe. The stock currently has a dividend yield of 4.63%. Currently there are 2 analysts that rate United Online a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on UNTD - FREE

TheStreet Quant Ratings rates United Online as a hold. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, expanding profit margins and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and a generally disappointing performance in the stock itself. Get the full United Online Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Morgan Stanley (MS) - FREE Research Report

Nicolaisen Donald T who is Director at Morgan Stanley sold 4,704 shares at $30.33 on Nov. 15, 2013. Following this transaction, the Director owned 69,883 shares meaning that the stake was reduced by 6.31% with the 4,704 share transaction.

The shares most recently traded at $30.67, up $0.34, or 1.1% since the insider transaction.

The average volume for Morgan Stanley has been 13.3 million shares per day over the past 30 days. Morgan Stanley has a market cap of $59.2 billion and is part of the financial sector and financial services industry. Shares are up 58.68% year to date as of the close of trading on Friday.

Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals worldwide. The stock currently has a dividend yield of 0.67%. The company has a P/E ratio of 17.9. Currently there are 13 analysts that rate Morgan Stanley a buy, 1 analyst rates it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MS - FREE

TheStreet Quant Ratings rates Morgan Stanley as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, compelling growth in net income, attractive valuation levels and impressive record of earnings per share growth. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Morgan Stanley Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Solera Holdings (SLH) - FREE Research Report

Kingsbury Arthur F who is Director at Solera Holdings sold 5,232 shares at $63.22 on Nov. 15, 2013. Following this transaction, the Director owned 29,143 shares meaning that the stake was reduced by 15.22% with the 5,232 share transaction.

The shares most recently traded at $65.62, up $2.40, or 3.66% since the insider transaction. Historical insider transactions for Solera Holdings go as follows:

  • 24-Week # shares sold: 10,000

The average volume for Solera Holdings has been 265,200 shares per day over the past 30 days. Solera Holdings has a market cap of $4.5 billion and is part of the technology sector and computer software & services industry. Shares are up 21.73% year to date as of the close of trading on Friday.

Solera Holdings, Inc. provides software and services to insurance companies, collision repair facilities, independent assessors, automotive recyclers, automotive dealers, and households in the United States and internationally. The stock currently has a dividend yield of 1.05%. The company has a P/E ratio of 60.8. Currently there are 6 analysts that rate Solera Holdings a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on SLH - FREE

TheStreet Quant Ratings rates Solera Holdings as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations, expanding profit margins and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Solera Holdings Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Opko Health (OPK) - FREE Research Report

Frost Phillip Md Et Al who is CEO & Chairman at Opko Health bought 25,600 shares at $10.09 on Nov. 15, 2013. Following this transaction, the CEO & Chairman owned 137.1 million shares meaning that the stake was reduced by 0.02% with the 25,600 share transaction.

The shares most recently traded at $9.97, down $0.12, or 1.21% since the insider transaction.

The average volume for Opko Health has been 4.8 million shares per day over the past 30 days. Opko Health has a market cap of $4.1 billion and is part of the health care sector and health services industry. Shares are up 110.6% year to date as of the close of trading on Friday.

Opko Health, Inc., a pharmaceutical and diagnostics company, engages in the discovery, development, and commercialization of novel and proprietary technologies. It operates in two segments, Pharmaceuticals and Diagnostics. Currently there are 3 analysts that rate Opko Health a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on OPK - FREE

TheStreet Quant Ratings rates Opko Health as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including feeble growth in the company's earnings per share and deteriorating net income. Get the full Opko Health Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Data for this article provided by Zacks Investment Research
null